Skip to main content
    P

    ProMIS Neurosciences Inc. (PMN)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $8.70
    +0.42 (+5.01%)

    Market Cap: $74.30M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    80%(24/30)
    Avg Surprise
    -1.29%
    Streak
    1 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-1.82
    Range$-1.85 - $-1.79
    2 analysts
    EPS RevisionsNo revisions (7d)No revisions (30d)
    EPS Estimate DriftChange to current
    90d ago$0.00n/a
    60d ago$0.00n/a
    30d ago$-2.15+15.1%
    7d ago$-2.13+14.4%
    Current$-1.82
    Revenue Consensus
    $0
    Range$0 - $0
    7 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-2.17
    Range$-2.30 - $-2.04
    2 analysts
    Revenue Consensus
    $0
    Range$0 - $0
    8 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-2.17---
    Sep 26EST
    		-$-1.82---
    Jun 26
    Reported Aug 13
    		$-1.28$-1.45+11.72%Beat+87.2%
    Mar 26
    Reported May 12
    		$-1.26$-0.20-516.10%Miss+82.8%
    Dec 25
    Reported Mar 25
    		$-30.05$-6.71-347.84%Miss-25141.7%
    Sep 25
    Reported Nov 12
    		$-8.40$-9.99+15.92%Beat-177.3%
    Jun 25
    Reported Aug 13
    		$-9.98$-6.04-65.23%Miss-123.3%
    Mar 25
    Reported May 12
    		$-7.35$-4.30-70.93%Miss-13.4%
    Dec 24
    Reported Mar 31
    		$0.12$-0.16+175.00%Beat+141.4%
    Sep 24
    Reported Nov 14
    		$10.86$-2.42+548.76%Beat+266.6%
    Jun 24
    Reported Aug 8
    		$-4.47$-4.85+7.84%Beat-1555.6%
    Mar 24
    Reported Apr 1
    		$-6.48$-6.87+5.68%Beat-1020.9%
    Dec 23
    Reported Mar 6
    		$-0.29$-0.27-7.41%Miss+75.2%
    Sep 23
    Reported Nov 14
    		$-6.52$-11.42+42.91%Beat-487.4%
    Jun 23
    Reported Aug 14
    		$-0.27$-0.27+0.00%Beat+43.7%
    Mar 23
    Reported May 15
    		$-0.58$-0.58+0.33%Beat+3.7%
    Dec 22
    Reported Mar 8
    		$-1.17N/AN/ABeat-262.8%
    Sep 22
    Reported Nov 14
    		$-1.11$-0.85-30.59%Miss-760.5%
    Jun 22
    Reported Aug 12
    		$-0.48N/AN/ABeat-910.5%
    Mar 22
    Reported May 13
    		$-0.60N/AN/ABeat+51.0%
    Dec 21
    Reported Mar 17
    		$-0.32N/AN/ABeat-195.6%
    Sep 21
    Reported Nov 12
    		$-0.13N/AN/ABeat+78.5%
    Jun 21
    Reported Aug 12
    		$-0.05N/AN/ABeat+92.1%
    Mar 21
    Reported May 14
    		$-1.22$-1.49+17.83%Beat-12144.0%
    Dec 20
    Reported Mar 31
    		$-0.11N/A+75.76%Beat-991.0%
    Sep 20
    Reported Nov 11
    		$-0.60$-0.60+0.00%Beat-5900.0%
    Jun 20
    Reported Aug 13
    		$-0.60$-0.60+0.00%Beat-5900.0%
    Mar 20
    Reported May 13
    		$-0.01N/A+97.67%Beat+0.0%
    Dec 19
    Reported Mar 18
    		$-0.01$-0.01+0.00%Beat+0.0%
    Sep 19
    Reported Nov 14
    		$-0.01$-0.01+0.00%Beat+0.0%
    Jun 19
    Reported Aug 13
    		$-0.01$-0.01+0.00%Beat+0.0%
    Mar 19
    Reported May 14
    		$-0.01$-0.01+0.00%Beat+0.0%
    Dec 18
    Reported Mar 15
    		$-0.01$-0.01+0.00%Beat+0.0%
    Sep 18
    Reported Nov 13
    		$-0.01$-0.01+0.00%Beat+0.0%
    Jun 18
    Reported Aug 14
    		$-0.01$-0.01+0.00%Beat+97.6%
    Mar 18
    Reported May 11
    		$-0.01$-0.01+0.00%Beat+96.9%
    Dec 17
    Reported Mar 14
    		$-0.01$-0.01+0.00%Beat+96.7%
    Sep 17
    Reported Nov 13
    		$-0.01$-0.01+0.00%Beat-
    Jun 17
    Reported Aug 11
    		$-0.42N/AN/ABeat-
    Mar 17
    Reported May 9
    		$-0.32N/AN/ABeat-
    Dec 16
    Reported Mar 15
    		$-0.30N/AN/ABeat-

    Key Metrics

    Valuation
    P/E Ratio-0.21EV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-172.30%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest Coverage37.20x
    Current Ratio7.85xQuick Ratio7.85x
    Trading Statistics
    Beta-0.25Avg Volume34.26K
    52-Week High$27.4052-Week Low$6.27

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$9.10
    SMA 20$10.47
    SMA 50$12.59
    SMA 200$12.85
    EMA 10$9.26
    EMA 20$10.19
    EMA 50$11.64
    EMA 200$12.46

    MACD

    Line: -1.18Signal: -1.09Hist: -0.08

    ADX

    ADX: 31.3+DI: 11.7-DI: 27.2

    Aroon & PSAR

    Aroon UpN/A
    Aroon Down100.0
    PSAR$9.50

    Bollinger Bands

    Upper Band$14.09
    Lower Band$6.86
    %B Position6899%(Upper)
    Band Width0.25

    RSI (14-Day)

    Neutral
    31.3

    Momentum Oscillators

    Stoch %K8.7
    Stoch %D8.7
    Williams %R-80.4
    ROC (10d)-7.2%
    Momentum-0.68
    CCI (20d)-90.6
    MFI (14d)20.1

    Volatility Measures

    ATR (14d)$0.94(10.8%)
    StdDev (20d)1.81
    Hist Vol76.9%(High)

    Volume Flow

    VWAP$8.52
    OBV330.6M
    AD Line79.5B
    CMF (20d)-0.429

    Volume Metrics

    Avg Vol (20d)34.9K
    Vol Ratio1.0x
    VWMA (20d)$10.70

    Pivot Points

    R3$9.33
    R2$9.07
    R1$8.68
    Pivot Point$8.42
    S1$8.03
    S2$7.77
    S3$7.38

    Advanced Oscillators

    TSI-38.79
    Ultimate Osc39.5
    KST-310.85

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$0$0$0$0$0$0$0$0$0$0$0$0
    Cost of Revenue$0$0N/A$0$0$0$4.32M$0$0$0N/A$0
    Gross Profit$0$0N/A$0$0$0$-4,320,498$0$0$0N/A$0
    Operating Expenses$12.27M$8.64M$10.77M$11.75M$10.18M$7.46M$6.00M$4.43M$2.71M$3.68M$3.87M$2.52M
    R&D$9.52M$6.97M$9.37M$9.80M$8.75M$5.46M$4.32M$2.56M$1.63M$2.12M$2.23M$1.14M
    SG&A$2.74M$1.67M$1.40M$1.95M$1.43M$2.00M$1.68M$1.87M$1.09M$1.55M$1.65M$1.38M
    Operating Income$-12,266,399$-8,644,895$-10,772,120$-11,750,432$-10,184,661$-7,460,095$-6,002,444$-4,434,677$-2,713,706$-3,676,651$-3,874,638$-2,517,540
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$0$0$0$0$0$0$0$0$0$76,775$76,795$75,413
    Income Before Tax$-11,729,656$-8,244,372$-10,679,681$-11,580,126$-10,117,029$-7,347,903$-238,207$9.28M$-2,623,657$-3,635,088$-4,006,997$-2,360,648
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-11,729,656$-8,244,372$-10,674,089$-11,580,126$-10,117,029$-7,347,903$-238,207$9.28M$-2,623,657$-3,635,088$-3,580,429$-2,360,648
    EBITDA$-11,729,656$-8,244,372$-10,679,681$-11,580,126$-10,117,029$-7,347,903$-238,207$9.28M$-2,623,657$-3,558,313$-3,912,181$-2,284,890
    EBIT$-11,729,656$-8,244,372$-10,679,681$-11,580,126$-10,117,029$-7,347,903$-238,207$9.28M$-2,623,657$-3,558,313$-3,930,202$-2,285,235
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about PMN

    News

    H.C. Wainwright reiterates ProMIS Neurosciences stock rating on new hire By Investing.com

    H.C. Wainwright has reiterated its Buy rating and $18.00 price target for ProMIS Neurosciences (NASDAQ:PMN) following the company's appointment of Ivana Rubino, Ph.D....

    Investing.com Canada•10/12/26•Bullish

    Promis Neurosciences Inc (PMN-Q) Stock Price and News

    This article provides stock price and news information for Promis Neurosciences Inc (PMN-Q). It includes real-time stock data, recent news headlines detailing corporate announcements, analyst ratings...

    The Globe and Mail•10/8/26•Somewhat-Bullish

    Form 4 ProMIS Neurosciences Inc. For: 7 October By Investing.com

    This article from Investing.com announces the filing of a Form 4 for ProMIS Neurosciences Inc. dated October 7th. It provides no further details about the Form 4 itself...

    Investing.com UK•10/7/26•Neutral

    Form 4 ProMIS Neurosciences Inc. For: 7 October By Investing.com

    This article announces the filing of a Form 4 for ProMIS Neurosciences Inc. on October 7th. Form 4 is a document that must be filed with the U.S. Securities and Exchange Commission (SEC) by company insiders to report...

    Investing.com India•10/7/26•Neutral

    Form 4 ProMIS Neurosciences Inc. For: 7 October By Investing.com

    This article from Investing.com is a standard financial announcement titled "Form 4 ProMIS Neurosciences Inc....

    Investing.com Nigeria•10/7/26•Neutral

    PMN Valuation and Fair Value

    P/E
    -0.2x
    P/B
    1.6x
    See GNG's fair value

    PMN Profitability: Margins, ROIC and FCF

    Operating margin
    0.0%
    Net margin
    0.0%
    ROE
    -172.3%

    PMN Competitors

    CompanyTicker
    LENSAR IncLNSR
    OKYO Pharma LimitedOKYO
    CareCloud, Inc.CCLD
    Outset Medical IncOM
    InterCure Ltd.INCR
    MAIA Biotechnology Inc.MAIA
    Electrocore LLCECOR
    Oncolytics Biotech IncONCY

    Sector: Healthcare

    PMN Analyst Ratings

    Consensus
    Buy
    Analysts
    8
    Strong Buy
    2
    Buy
    6
    Hold
    0
    Sell
    0
    Strong Sell
    0

    PMN Bull Case vs Bear Case

    Bull case

    • 100.0% of PMN's analyst ratings are Buy or Strong Buy.

    PMN Earnings: Beat Rate and Next Report

    Beat rate
    4 of 8 quarters (50.0%)
    Average surprise
    -31.1%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-1.82
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    0 up, 0 down

    Frequently Asked Questions About PMN

    Does PMN pay dividends?

    ProMIS Neurosciences Inc. (PMN) does not currently pay a regular dividend.

    What is PMN's market cap?

    ProMIS Neurosciences Inc. (PMN) has a market capitalization of $74.30M with a current stock price of $8.70.

    Related stocks

    Sector: Healthcare

    All stocks starting with P

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In